O

Ortivus AB
STO:ORTI B

Watchlist Manager
Ortivus AB
STO:ORTI B
Watchlist
Price: 1.44 SEK 2.86%
Market Cap: 63.8m SEK
Have any thoughts about
Ortivus AB?
Write Note

Ortivus AB
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ortivus AB
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
O
Ortivus AB
STO:ORTI B
Capital Expenditures
-kr10.8m
CAGR 3-Years
-58%
CAGR 5-Years
-67%
CAGR 10-Years
N/A
RaySearch Laboratories AB (publ)
STO:RAY B
Capital Expenditures
-kr209.3m
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
N/A
ContextVision AB
OSE:CONTX
Capital Expenditures
kr5.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mentice AB
STO:MNTC
Capital Expenditures
-kr7m
CAGR 3-Years
35%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Sectra AB
STO:SECT B
Capital Expenditures
-kr250.7m
CAGR 3-Years
-55%
CAGR 5-Years
-48%
CAGR 10-Years
N/A
K
Kontigo Care AB
STO:KONT
Capital Expenditures
-kr10.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Ortivus AB
Glance View

Market Cap
63.8m SEK
Industry
Health Care

Ortivus AB engages in the development and sale of clinical devices and systems. The company is headquartered in Danderyd, Stockholm. The firm is engaged in the development of mobile surveillance and communication solutions, forming a decision support system. Its offering comprises: MobiMed Smart, a decision support system, which allows ambulance personnel to handle documentation, monitoring and introduce a structured approach in prehospital care; CoroNet, a mobile surveillance solution which allows patients to move freely under supervision of medical staff and provides healthcare professionals with monitoring information. In addition, the Company provides a wide range of services, such as support, implementation, training and consulting, among others. The Company’s customer base includes mainly ambulance services and emergency departments.

ORTI B Intrinsic Value
2.27 SEK
Undervaluation 37%
Intrinsic Value
Price
O

See Also

What is Ortivus AB's Capital Expenditures?
Capital Expenditures
-10.8m SEK

Based on the financial report for Dec 31, 2023, Ortivus AB's Capital Expenditures amounts to -10.8m SEK.

What is Ortivus AB's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-67%

Over the last year, the Capital Expenditures growth was -77%. The average annual Capital Expenditures growth rates for Ortivus AB have been -58% over the past three years , -67% over the past five years .

Back to Top